Imagen de Portada

DrugImproverGPT: A Large Language Model for Drug Optimization with Fine-Tuning via Structured Policy Optimization

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Liu, Xuefeng, Jiang, Songhao, Chen, Siyu, Yang, Zhuoran, Chen, Yuxin, Foster, Ian, Stevens, Rick
Formato:	Preprint
Publicado:	2025
Materias:	Machine Learning Computation and Language Biomolecules
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

ScaffoldGPT: A Scaffold-based GPT Model for Drug Optimization
por: Liu, Xuefeng, et al.
Publicado: (2025)

ControllableGPT: A Ground-Up Designed Controllable GPT for Molecule Optimization
por: Liu, Xuefeng, et al.
Publicado: (2025)

FragmentGPT: A Unified GPT Model for Fragment Growing, Linking, and Merging in Molecular Design
por: Liu, Xuefeng, et al.
Publicado: (2025)

Large Language Model Agent for Modular Task Execution in Drug Discovery
por: Ock, Janghoon, et al.
Publicado: (2025)

DrugLLM: Open Large Language Model for Few-shot Molecule Generation
por: Liu, Xianggen, et al.
Publicado: (2024)

K-Paths: Reasoning over Graph Paths for Drug Repurposing and Drug Interaction Prediction
por: Abdullahi, Tassallah, et al.
Publicado: (2025)

Decomposed Direct Preference Optimization for Structure-Based Drug Design
por: Cheng, Xiwei, et al.
Publicado: (2024)

Pushing the boundaries of Structure-Based Drug Design through Collaboration with Large Language Models
por: Gao, Bowen, et al.
Publicado: (2025)

Artificial Intelligence Approaches for Anti-Addiction Drug Discovery
por: Chen, Dong, et al.
Publicado: (2025)

Structure-Enhanced Protein Instruction Tuning: Towards General-Purpose Protein Understanding with LLMs
por: Wu, Wei, et al.
Publicado: (2024)

Probe Before You Edit: Probing-Guided Molecular Optimization for LLM Agents in Structure-Based Drug Design
por: Yang, Zaifei, et al.
Publicado: (2026)

When SMILES have Language: Drug Classification using Text Classification Methods on Drug SMILES Strings
por: Wasi, Azmine Toushik, et al.
Publicado: (2024)

Systems-Structure-Based Drug Design
por: Zaballa, Vincent D., et al.
Publicado: (2024)

Scaffold-Based Multi-Objective Drug Candidate Optimization
por: Kruel, Agustin, et al.
Publicado: (2022)

PKAG-DDI: Pairwise Knowledge-Augmented Language Model for Drug-Drug Interaction Event Text Generation
por: Wang, Ziyan, et al.
Publicado: (2025)

Monte Carlo Tree Diffusion with Multiple Experts for Protein Design
por: Liu, Xuefeng, et al.
Publicado: (2025)

Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery
por: Lan, Jing, et al.
Publicado: (2025)

Fragment and Geometry Aware Tokenization of Molecules for Structure-Based Drug Design Using Language Models
por: Fu, Cong, et al.
Publicado: (2024)

A Hybrid Computational Intelligence Framework with Metaheuristic Optimization for Drug-Drug Interaction Prediction
por: Shamami, Maryam Abdollahi, et al.
Publicado: (2025)

FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling
por: Zhang, Zaixi, et al.
Publicado: (2024)

DrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposing
por: Lu, Yingzhou, et al.
Publicado: (2024)

A Large-Scale Dataset for Molecular Structure-Language Description via a Rule-Regularized Method
por: Cai, Feiyang, et al.
Publicado: (2026)

DrugPlayGround: Benchmarking Large Language Models and Embeddings for Drug Discovery
por: Liu, Tianyu, et al.
Publicado: (2026)

Generative Model for Small Molecules with Latent Space RL Fine-Tuning to Protein Targets
por: Sob, Ulrich A. Mbou, et al.
Publicado: (2024)

Large Language Models for Controllable Multi-property Multi-objective Molecule Optimization
por: Dey, Vishal, et al.
Publicado: (2025)

Structure-based Drug Design with Equivariant Diffusion Models
por: Schneuing, Arne, et al.
Publicado: (2022)

Rethinking Drug-Drug Interaction Modeling as Generalizable Relation Learning
por: Xu, Dong, et al.
Publicado: (2026)

Preferential Multi-Objective Bayesian Optimization for Drug Discovery
por: Dang, Tai, et al.
Publicado: (2025)

Zero-Shot 3D Drug Design by Sketching and Generating
por: Long, Siyu, et al.
Publicado: (2022)

Quantum-inspired Reinforcement Learning for Synthesizable Drug Design
por: Wang, Dannong, et al.
Publicado: (2024)

Binding-Adaptive Diffusion Models for Structure-Based Drug Design
por: Huang, Zhilin, et al.
Publicado: (2024)

Geometric-informed GFlowNets for Structure-Based Drug Design
por: Lee, Grayson, et al.
Publicado: (2024)

DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
por: Li, Kun, et al.
Publicado: (2025)

Assessing Reusability of Deep Learning-Based Monotherapy Drug Response Prediction Models Trained with Omics Data
por: Overbeek, Jamie C., et al.
Publicado: (2024)

Integrating Protein Dynamics into Structure-Based Drug Design via Full-Atom Stochastic Flows
por: Zhou, Xiangxin, et al.
Publicado: (2025)

Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling
por: Yang, Yuwei, et al.
Publicado: (2024)

Site4Drug: Predicting Drug-Binding Target Sites with an AI Agent
por: Kim, Taehan, et al.
Publicado: (2026)

Conditional Chemical Language Models are Versatile Tools in Drug Discovery
por: Zhu, Lu, et al.
Publicado: (2025)

MolCRAFT: Structure-Based Drug Design in Continuous Parameter Space
por: Qu, Yanru, et al.
Publicado: (2024)

On Novel Approach for Computing Distance based Indices of Anti-tuberculosis Drugs
por: Gunawardhana, D. C., et al.
Publicado: (2024)